Impact of investigational microbiota therapeutic RBX2660 on the gut microbiome and resistome revealed by a placebo-controlled clinical trial.

Suryang KwakJooHee ChoiTiffany HinkKimberly A ReskeKenneth BlountCourtney JonesMargaret H BostXiaoqing SunCarey-Ann D BurnhamErik R DubberkeGautam Dantasnull null

Published in: Microbiome (2020)

ClinicalTrials.gov, NCT02299570 . Registered 19 November 2014 Video Abstract.

Keyphrases

phase ii
placebo controlled
clinical trial
double blind
open label
phase iii
study protocol
phase ii study
randomized controlled trial
radiation therapy
locally advanced